Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director comp.
Appointed COO
Jasper Therapeutics, Inc. (AMHCU) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/13/2023 144 Form 144 - Report of proposed sale of securities:
10/10/2023 SC 13G SPHERA FUNDS MANAGEMENT LTD. reports a 5.1% stake in Jasper Therapeutics, Inc.
10/10/2023 8-K Investor presentation
Docs: "CORPORATE PRESENTATION, DATED OCTOBER 2023"
10/10/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Jasper Therapeutics Announces IND Clearance for Phase 1b/2a Study of Subcutaneous Briquilimab in Chronic Spontaneous Urticaria"
09/26/2023 4 CROSS HERB (CFO) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns: Granted 550,000 options to buy @ $0.78, valued at $429k
09/26/2023 3 CROSS HERB (CFO) has filed a Form 3 on Jasper Therapeutics, Inc.
08/11/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/11/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/11/2023 8-K Quarterly results
Docs: "Jasper Therapeutics Reports Second Quarter 2023 Financial Results and Provides a Business Update"
06/08/2023 4 Kapoor Vishal (Director) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns: Granted 47,000 options to buy @ $1.6, valued at $75.2k
06/08/2023 4 Klein Lawrence Otto (Director) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns: Granted 47,000 options to buy @ $1.6, valued at $75.2k
06/08/2023 4 EMSTER KURT VON (Director) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns: Granted 47,000 options to buy @ $1.6, valued at $75.2k
06/08/2023 4 Shizuru Judith Anne (Director) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns: Granted 47,000 options to buy @ $1.6, valued at $75.2k
06/08/2023 4 Nolet Chris (Director) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns: Granted 47,000 options to buy @ $1.6, valued at $75.2k
06/08/2023 4 Lis William (Director) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns: Granted 47,000 options to buy @ $1.6, valued at $75.2k
06/08/2023 4 French Anna Louise (Director) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns: Granted 47,000 options to buy @ $1.6, valued at $75.2k
06/08/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "CERTIFICATE OF AMENDMENT TO THE SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF",
"JASPER THERAPEUTICS, INC. AMENDED AND RESTATED 2022 INDUCEMENT EQUITY INCENTIVE PLAN"
06/02/2023 8-K Investor presentation
Docs: "CORPORATE PRESENTATION, DATED JUNE 2023"
05/08/2023 EFFECT Form EFFECT - Notice of Effectiveness:
05/05/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
04/21/2023 ARS Form ARS - Annual Report to Security Holders:
04/21/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/21/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/14/2023 144 Form 144 - Report of proposed sale of securities:
04/14/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/14/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/14/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/14/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/14/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/14/2023 8-K Quarterly results
04/13/2023 144 Form 144 - Report of proposed sale of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy